Combination Therapy with Inolimomab and Etanercept for Severe Steroid-Refractory Acute Graft-versus-Host Disease

网站地图 | English | 公务邮箱

About the library

Background
History
Leadership
Organization

Opening Hours
Collections
Help Via Email

Electronic Information Resources

Combination Therapy with Inolimomab and Etanercept for Severe Steroid-Refractory Acute Graft-versus-Host Disease

详细信息查看全文

作者：Lenneke F.J. van Groningen¹ ; ² ; ^{Lenneke.vanGroningen@radboudumc.nl" class="auth_mail" title="E-mail the corresponding author} ; Aleida M. Liefferink¹ ; Anton F.J. de Haan³ ; Nicolaas P.M. Schaap¹ ; J. Peter Donnelly¹ ; ² ; Nicole M.A. Blijlevens¹ ; ² ; Walter J.F.M. van der Velden¹ ; ²
关键词：Allogeneic stem cell transplantation ; Acute GVHD ; Steroid refractory ; Inolimomab ; Etanercept
刊名：Biology of Blood and Marrow Transplantation
出版年：2016
出版时间：January 2016
年：2016
卷：22
期：1
页码：179-182
全文大小：172 K

文摘

•: Steroid-refractory aGVHD remains an important cause of morbidity and mortality after allogeneic stem cell transplantation.
•: We examined a combination therapy with inolimomab and etanercept for patients with a steroid-refractory aGVHD.
•: The combination of inolimomab and etanercept for steroid-refractory aGVHD failed to improve the dismal prognosis of severe steroid-refractory aGVHD.

NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.